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Presented here is a simple method for cross-validated genome-wide association studies 
(cvGWAS). Focusing on phenotype prediction, the method is able to reveal a significant 
amount of missing heritability by properly selecting a small number of loci with implicit 
predictive ability. The results provide new insights into the missing heritability problem and 
the underlying genetic architecture of complex traits. 
Recently, the case of missing heritability has drawn a lot of attention in genetics of complex 
traits1,2,3,4,5,6,7. It has been widely noticed that for many complex traits, the loci uncovered by means 
of e.g. genome-wide association studies (GWAS) could only explain a minor proportion of the 
phenotypic variance, even though the observed heritability of the trait is much higher. Strategies 
have been proposed to search for the sources of such missing heritability4, e.g. capturing additive 
genetic variance using polygenic effects across the genome5,8 and mapping quantitative trait loci 
(QTL) using a powerful design7. However, even the use of all the genomic variants could not fully 
explain the missing heritability. Here, I propose a simple method to perform association mapping 
based on genomic variants’ predictive ability, explain the reason why the estimation of narrow sense 
heritability using all the markers across the genome is not reliable, and show that the underlying 
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heritability can be much higher than the conventional estimate and can even be well captured by a 
rather small number of QTL.
Forty-nine traits in Arabidopsis thaliana9 (9 flowering, 21 developmental, 12 defense and 7 
ionomics) were analyzed, with the sample size varied from 84 to 194 inbred lines. The Arabidopsis 
accessions were genotyped using a 250K SNP (single nucleotide polymorphism) array, where 
216,130 SNPs were available in the analysis. Instead of screening the genome using ordinary 
GWAS p-values, each SNP was assessed for their individual predictive ability by a 5-fold cross 
validation, i.e. the samples were split into a training (80%) and a test (20%) set for five replicates, 
without overlap among the five test sets. A linear regression of the phenotype on the SNP genotype 
was fitted in the training set for each marker, and the estimated model was used to perform out-of-
sample prediction in the test set. The predictive ability of an individual SNP was evaluated via an 
R2, which is the squared correlation coefficient between the true phenotypic measurements and their 
predicted values in each of the five test sets. The mean of the five R2 values, denoted as R2SNP, 
provided an estimate of the proportion of phenotypic variance captured by the SNP. It should be 
noted that such a predictive ability measurement is not a function of the p-value in ordinary GWAS 
(e.g. Fig. 1). Namely, the p-values obtained in GWAS tend to under-estimate the predictive 
performance of the SNPs. Comparison of the association results based on p-values and R2SNP for all 
the analyzed traits are given in Supplementary Figure 1-49.
For each trait, among the top 0.05% of the SNPs (n = 108) that had the highest R2SNP, the best 
subset with no more than 5 SNPs was selected by a forward stepwise selection procedure, based on 
a cross-validated assessment of their joint predictive power10. In order to compare the narrow sense 
heritability explained by the selected subset of SNPs (h2QTL) with that explained by the entire 
genome (h2G), another 5-fold cross validation was conducted. Both a random effects model using 
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only the selected SNPs (the QTL) as explanatory variables and a whole-genome ridge regression 
(SNP-BLUP11,12) were fitted in the training sets and used for predicting the phenotypic values in the 
test sets. h2QTL and h2G were estimated as the mean of the corresponding five squared correlation 
coefficients between the true and the predicted values5. For most traits, as shown in Figure 2, the 
small number of QTL had substantial advantage over the whole genome in terms of captured 
narrow sense heritability. The results indicated similar genetic architecture for the traits that belong 
to the same type. For instance, the defense and ionomics traits showed rather sparse architecture, 
whereas the flowering traits tended to be more polygenic. Interestingly, two gene expression traits 
of FRI and FLC, although regarded as flowering-related, appeared to have sparse architectures. For 
all the analyzed traits, details about the selected QTL and the heritability estimates are provided in 
Supplementary Table 2.
As a proof of concept, the results clearly showed that assessing the total narrow sense heritability 
using a large number of markers across the genome5,7,8 is not a valid approach. The main reason is 
that one has to substantially sacrifice the precision of the estimated QTL effects when incorporating 
too many markers as explanatory variables. When the QTL effects or the effects of the SNPs 
tagging the causal loci are properly estimated, the heritability inherited by the causal loci can be 
much better revealed than the entire genome. The results indicated that most of the missing 
heritability was missed by improper analytical methods. Beyond statistical significance in GWAS, 
more functional loci of complex traits can actually be revealed via assessments based on predictive 
performance.
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Methods
Software & URLs. The Arabidopsis thaliana GWAS data set is available at: https://
cynin.gmi.oeaw.ac.at/home/resources/atpolydb. All the analysis was conducted in R13 : http://
www.R-project.org/. The association mapping based on cross-validated R2SNP has been 
implemented in the “cvGWAS” package: https://r-forge.r-project.org/projects/cvgwas/. The forward 
stepwise selection procedure was executed by the “FWDselect” package14 : http://cran.r-project.org/
web/packages/FWDselect/. The random QTL effects model was fitted by the “hglm” package15 : 
http://cran.r-project.org/web/packages/hglm/. The whole-genome ridge regression (SNP-BLUP) 
was fitted by the “bigRR” package12 : http://cran.r-project.org/web/packages/bigRR/.  
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Figure Legends
Figure 1: Comparison of the SNPs predictive ability and p-values for FRI gene expression. 
The predictive ability is assessed by R2SNP (“Proportion of phenotypic variance explained via CV”), 
where CV stands for “cross validation”. The p-values were obtained using Wilcoxon test. The 
horizontal line indicates the Bonferroni-corrected genome-wide significant threshold, and the 
vertical line shows the cut-off that determines which SNPs are to be passed onto the forward 
selection procedure.
Figure 2: Comparison of the narrow sense heritability captured by the selected QTL (h2QTL) 
and the whole genome (h2G). Each colored point represents an analyzed trait. The color of each 
point shows the type of the trait, where blue, red, green and pink refer to flowering, developmental, 
defense and ionomics traits, respectively. The size of each point is proportional to the number of 
QTL selected (from 2 to 5). The cross on each point shows the standard error estimates based on the 
cross validation. The dashed line indicates equality of h2QTL and h2QTL as a visual guide.
Supplementary Table 1-2 and Supplementary Figure 1-49 are available as Supplementary 
Information from the journal website.
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This document contains the Supplementary Information for 
Revealing the missing heritability via cross-validated genome-wide association studies
by Shen, X. (2013)
Remarks:
• The Excel table format of Supplementary Table 2 can be downloaded at: https://
docs.google.com/file/d/0B2ixEvB0Gwt6SWhZcW1KQmx2Wmc/edit?usp=sharing
• In Supplementary Figure 1-49, the horizontal dashed line in each top panel is the Bonferroni-
corrected genome-wide significance threshold, and the vertical is the cut-off for selecting 
candidate SNPs to be passed onto the forward selection procedure. The phenotypic variance 
explained in the bottom panels was estimated by R2SNP.
• The link provided in Methods for the package “cvGWAS” is the project home page. For package 
download: https://r-forge.r-project.org/R/?group_id=1694. If the package is being built on R-
Forge, refer to https://r-forge.r-project.org/scm/viewvc.php/pkg/R/cvscore.R?
view=markup&revision=2&root=cvgwas for the source code of the main function cvscore(), 
which is a directly usable add-on function for the GWA analysis package GenABEL (Aulchenko 
2007 Bioinformatics).
Supplementary Table 1: Phenotypes analyzed. 
Refer to Atwell et al. (2010) for further details about phenotype description and scoring.
Phenotype ID Type Sample size Description Growth Conditions
SD 3 Flowering 162 Days to flowering 
time (FT) under 
Long Day (LD) 
and
Short Day(SD) +/- 
vernalization.
18℃, 8 hrs daylight.
FT10 5 Flowering 194 Flowering time 
(FT)
10℃, 16 hrs daylight.
FT16 6 Flowering 193 16℃, 16 hrs daylight.
FT22 7 Flowering 193 22℃, 16 hrs daylight.
Emco5 9 Defense 86 Disease presence 
or absence 
following 
inoculation with 
each isolate.
20-22℃, 10 hrs 
daylight, 70% humidity.
Emwa1 10 Defense 85
Hiks1 12 Defense 84
Lithium (Li7) 14 Ionomics 93 In planta ion 
concentration.
20℃, 16 hrs daylight.
Sulfur (S34) 19 Ionomics 93
Potassium (K39) 20 Ionomics 93
Manganese (Mn55) 22 Ionomics 93
Iron (Fe56) 23 Ionomics 93
Cobalt (Co59) 24 Ionomics 93
Zinc (Zn66) 27 Ionomics 93
AvrRpm1 33 Defense 84 Hypersensitive 
response.
20℃, 12 hrs daylight.
FLC 43 Flowering 167 FLC and FRI 
gene expression.
Growth in greenhouse,  
~20-22℃, 16 hrs 
daylight.FRI 44 Flowering 164
8W GH LN 46 Flowering 163 LN at FT. 20-22℃, natural light 
from the middle of 
October 2002 till 
March 2003, 
vernalized (8 wks, 4℃,  
8 hrs daylight).
0W GH LN 48 Flowering 135 20-22℃, natural light 
from the middle of 
October 2002 till 
March 2003.
FT Diameter Field 58 Flowering 180 Plant diameter at 
flowering (field).
Growth in field or 
greenhouse (20℃, 16 
hrs daylight), started in 
October.
Phenotype ID Type Sample size Description Growth Conditions
At1 65 175
At1 CFU2 66 175
As CFU2 68 175
Bs 69 175
Bs CFU2 70 175
At2 71 175
At2 CFU2 72 175
As2 73 175
DW 76 Developmental 95 Dry weight of 
plants.
Plants were grown for 
7 weeks at 23℃.
Silique 22 159 Developmental 95 Silique length. 22℃, 16 hrs daylight.
Germ 10 161 Developmental 177 Days to 
germination.
Stratified for 3 days at 
4℃ in the dark, 
followed by growth at 
10℃ with 16 hrs 
daylight.
Germ 16 162 Developmental 176 Stratified for 3 days at 
4℃ in the dark, 
followed by growth at 
16℃ with 16 hrs 
daylight.
Width 10 164 Developmental 176 Plant diameter. 10℃, 16 hrs daylight.
Width 16 165 Developmental 175 16℃, 16 hrs daylight.
Width 22 166 Developmental 175 22℃, 16 hrs daylight.
Chlorosis 16 168 Developmental 176 Visual chlorosis 
presence.
16℃, 16 hrs daylight.
Anthocyanin 10 170 Developmental 177 Visual 
anthocyanin 
presence.
10℃, 16 hrs daylight.
Anthocyanin 16 171 Developmental 176 16℃, 16 hrs daylight.
Anthocyanin 22 172 Developmental 177 22℃, 16 hrs daylight.
Leaf serr 10 173 Developmental 174 Level of leaf 
serration.
10℃, 16 hrs daylight.
Leaf roll 16 177 Developmental 176 Level of roll 
presence.
16℃, 16 hrs daylight.
Rosette Erect 22 179 Developmental 176 Presence of 
rosette erectness.
22℃, 16 hrs daylight.
Seedling Growth 272 Developmental 101 Seedling growth 
rate.
Seeds were grown for 
one week in the 
greenhouse under long 
day (16 hours light).
Phenotype ID Type Sample size Description Growth Conditions
Vern Growth 273 Developmental 111 Vegetative growth 
rate during 
vernalization.
Seeds were grown for 
one week in the 
greenhouse under long 
day (16 hours light), 
vernalized for 4 weeks 
(4℃, 16h light, 50% 
relative humidity).
After Vern Growth 274 Developmental 111 Vegetative growth 
rate after 
vernalization.
Seeds were grown for 
one week in the 
greenhouse under long 
day (16 hours light), 
vernalized for 4 weeks 
(4℃, 16 hrs light, 50% 
relative humidity)and 
then returned to 
greenhouse.
Secondary Dormancy 277 Developmental 94 Decrease in 
germination rate 
after prolonged 
exposure to cold 
temperature.
Fully after-ripened 
seeds were treated 
with a 1 and 6-week 
long exposure to 4℃.
Germ in dark 278 Developmental 94 Germination in 
the dark.
4℃, in the dark.
DSDS50 279 Developmental 110 Duration of seed 
dry storage 
required for 50% 
of the seeds to 
germinate.
Dry storage, followed 
by 25℃, 12 hrs day, 
20℃, 12 hrs night for 
1 week.
Storage 56 days 283 Developmental 111 Primary 
dormancy.
56 days dry storage.
Supplementary	  Table	  2 Summary	  of	  selected	  QTL	  for	  each	  analyzed	  trait	  and	  the	  heritability	  estimates	  compared	  to	  those	  by	  the	  whole	  genome.
h2 Narrow-­‐sense	  heritability	  estimated	  as	  the	  mean	  of	  the	  squared	  correlation	  coefficients	  between	  the	  true	  and	  the	  predicted	  phenotype	  in	  a	  5-­‐fold	  cross	  validation.
For	  h2_QTL,	  a	  random	  effects	  model	  using	  only	  the	  QTL	  as	  explanatory	  variables	  were	  fitted.	  For	  h2_GENOME,	  a	  whole-­‐genome	  ridge	  regression	  using	  all	  the	  SNPs	  were	  fitted.
se Standard	  error	  estimated	  via	  a	  5-­‐fold	  cross	  validation.
CHROMOSOME POSITION
SD Flowering 1 4593289 0.6063 0.0690 0.6517 0.0355
1 18903090
3 18923922
3 18929030
4 16084919
FT10 Flowering 2 13151174 0.5796 0.0432 0.5825 0.0370
4 16017869
5 6534392
5 18607728
FT16 Flowering 1 6369609 0.6448 0.0771 0.6328 0.0758
2 9611587
3 23090917
4 12519944
FT22 Flowering 1 6369765 0.5255 0.0701 0.6045 0.0690
4 12519944
5 2551768
5 2554284
5 6844135
Emco5 Defense 1 1430178 0.4539 0.0138 0.0768 0.0355
2 4185247
Emwa1 Defense 1 17250538 0.6452 0.0632 0.1221 0.0316
2 13008747
2 17934073
4 8196803
5 25721325
Hiks1 Defense 1 22583408 0.4195 0.0971 0.1581 0.0652
5 9299223
5 10841701
5 17477817
Li7 Ionomics 1 11096840 0.4292 0.1103 0.1824 0.0621
3 10620051
4 15226225
S34 Ionomics 2 621979 0.4796 0.0691 0.0358 0.0143
2 5755893
3 22362360
4 7788807
5 10133357
K39 Ionomics 1 10146885 0.5541 0.0468 0.1006 0.0493
1 17666204
1 28516934
4 6786084
5 11291662
Mn55 Ionomics 1 8502187 0.5565 0.0329 0.1146 0.0414
se(h2_GENOME)
SELECTED	  SNPS	  (QTL)
TRAIT TYPE h2_QTL se(h2_QTL) h2_GENOME
1 13853615
1 29996840
3 20599509
Fe56 Ionomics 3 7092529 0.5229 0.0522 0.0425 0.0142
3 7918007
3 16718549
4 795370
5 5611234
Co59 Ionomics 3 13135745 0.5556 0.0998 0.0600 0.0251
3 20321272
4 5514273
4 7592626
4 8569114
Zn66 Ionomics 1 21179549 0.6129 0.0855 0.0305 0.0067
2 6367225
2 7419526
3 9969573
5 26078291
avrRpm1 Defense 2 17504634 0.3796 0.0636 0.1607 0.0729
3 2270902
FLC Flowering 1 19790829 0.6054 0.1047 0.3710 0.0579
4 1507838
5 5883775
5 10172996
5 24786228
FRI Flowering 1 5989995 0.4252 0.0966 0.1771 0.0630
4 268809
8W	  GH	  LN Flowering 1 2005921 0.5711 0.0653 0.4772 0.0918
2 1977590
3 12358261
0W	  GH	  LN Flowering 1 2005921 0.6312 0.0361 0.5086 0.0639
3 14131141
4 16309006
5 18625726
FT	  Diameter	  Field Flowering 2 8405178 0.3911 0.0424 0.1886 0.0262
2 14616766
4 15770883
5 433959
5 26809133
At1 Defense 1 16010365 0.3588 0.0551 0.0457 0.0218
3 2613557
4 10057494
5 19958648
At1	  CFU2 Defense 1 6629169 0.3444 0.0756 0.0375 0.0194
1 7898750
1 8237125
4 12080070
As	  CFU2 Defense 1 2275779 0.3674 0.0308 0.0063 0.0045
1 22984248
4 5814807
4 17180545
5 10058335
Bs Defense 1 8298611 0.3664 0.0642 0.0251 0.0102
1 28757586
3 23000304
4 18459798
Bs	  CFU2 Defense 1 17212115 0.3688 0.0847 0.0547 0.0230
1 19333698
2 17078909
4 10857336
At2 Defense 1 16776084 0.3845 0.1021 0.0613 0.0158
1 18397234
4 6262290
5 555655
At2	  CFU2 Defense 1 25379336 0.2893 0.0569 0.0124 0.0059
2 8414639
3 12697805
5 19565066
As2 Defense 1 18040347 0.3115 0.0324 0.0173 0.0046
2 16474284
4 5004139
DW Developmental 3 1801701 0.6587 0.0513 0.1186 0.0204
3 6145352
3 14997936
3 20154975
4 17026991
Silique	  22 Developmental 1 2968159 0.5579 0.0354 0.2079 0.0453
2 17801496
4 403634
5 17364116
5 18640009
Germ	  10 Developmental 1 1429372 0.4449 0.0381 0.0581 0.0039
1 9638902
3 6487689
3 15305943
4 179908
Germ	  16 Developmental 1 1551963 0.4554 0.0778 0.1082 0.0439
1 10488901
2 10188094
4 9061476
5 17648491
Width	  10 Developmental 1 21041405 0.5254 0.0641 0.2292 0.0627
3 20976454
5 6373912
5 14131512
5 16952385
Width	  16 Developmental 1 12615860 0.4068 0.0359 0.1812 0.0651
3 15719656
3 20882629
5 18262951
Width	  22 Developmental 1 21752821 0.4021 0.0610 0.0991 0.0513
1 24461138
3 15753112
4 15083851
4 17570674
Chlorosis	  16 Developmental 1 23272710 0.4038 0.0305 0.0115 0.0048
1 30244136
2 15088120
4 9996734
5 6416385
Anthocyanin	  10 Developmental 1 1921764 0.4588 0.0871 0.1232 0.0755
1 4865222
2 1937020
2 17731129
3 8594331
Anthocyanin	  16 Developmental 3 7931982 0.3999 0.0442 0.0407 0.0188
3 17584494
3 18237858
5 14776227
5 18408198
Anthocyanin	  22 Developmental 1 16933062 0.3841 0.0630 0.1058 0.0583
2 18684705
3 18230944
5 26305400
Leaf	  serr	  10 Developmental 1 21866684 0.3992 0.0317 0.1721 0.0534
1 25545686
3 711663
5 809032
Leaf	  roll	  16 Developmental 1 1543644 0.3579 0.0836 0.1223 0.0593
1 12541124
5 9691412
Rosette	  Erect	  22 Developmental 1 10702954 0.4682 0.0760 0.1833 0.0574
4 158958
4 5423725
5 15438762
5 17474995
Seedling	  Growth Developmental 1 1409102 0.5260 0.0797 0.0298 0.0190
1 3351283
2 5985892
3 1193580
Vern	  Growth Developmental 1 22861979 0.6022 0.0722 0.1161 0.0399
1 25496457
3 10027171
4 16443666
5 21775600
After	  Vern	  Growth Developmental 3 11799463 0.3852 0.0926 0.0788 0.0207
4 7543367
4 17416904
Secondary	  Dormancy Developmental 1 22945590 0.6968 0.0445 0.2840 0.0689
3 15137506
3 16164636
3 22951949
5 6097616
Germ	  in	  dark Developmental 1 10725637 0.6287 0.0516 0.1960 0.0418
4 7403647
5 10511334
5 22310661
DSDS50 Developmental 1 1045551 0.6611 0.0555 0.2830 0.0569
1 11593466
2 10750002
3 21285974
4 14688343
Storage	  56	  days Developmental 1 863771 0.6353 0.0230 0.3598 0.0424
1 19520347
2 883192
2 5713096
5 15859708
Comparison of p-values and predictive ability
Genome-wide association mapping via Wilcoxon test
Predictive ability assessed by cross validation
Supplementary Figure 1 - Results of GWAS p-values and cross-validated predictive ability for SD
Comparison of p-values and predictive ability
Genome-wide association mapping via Wilcoxon test
Predictive ability assessed by cross validation
Supplementary Figure 2 - Results of GWAS p-values and cross-validated predictive ability for FT10
Comparison of p-values and predictive ability
Genome-wide association mapping via Wilcoxon test
Predictive ability assessed by cross validation
Supplementary Figure 3 - Results of GWAS p-values and cross-validated predictive ability for FT16
Comparison of p-values and predictive ability
Genome-wide association mapping via Wilcoxon test
Predictive ability assessed by cross validation
Supplementary Figure 4 - Results of GWAS p-values and cross-validated predictive ability for FT22
Comparison of p-values and predictive ability
Genome-wide association mapping via Wilcoxon test
Predictive ability assessed by cross validation
Supplementary Figure 5 - Results of GWAS p-values and cross-validated predictive ability for Emco5
Comparison of p-values and predictive ability
Genome-wide association mapping via Wilcoxon test
Predictive ability assessed by cross validation
Supplementary Figure 6 - Results of GWAS p-values and cross-validated predictive ability for Emwa1
Comparison of p-values and predictive ability
Genome-wide association mapping via Wilcoxon test
Predictive ability assessed by cross validation
Supplementary Figure 7 - Results of GWAS p-values and cross-validated predictive ability for Hiks1
Comparison of p-values and predictive ability
Genome-wide association mapping via Wilcoxon test
Predictive ability assessed by cross validation
Supplementary Figure 8 - Results of GWAS p-values and cross-validated predictive ability for Li7
Comparison of p-values and predictive ability
Genome-wide association mapping via Wilcoxon test
Predictive ability assessed by cross validation
Supplementary Figure 9 - Results of GWAS p-values and cross-validated predictive ability for S34
Comparison of p-values and predictive ability
Genome-wide association mapping via Wilcoxon test
Predictive ability assessed by cross validation
Supplementary Figure 10 - Results of GWAS p-values and cross-validated predictive ability for K39
Comparison of p-values and predictive ability
Genome-wide association mapping via Wilcoxon test
Predictive ability assessed by cross validation
Supplementary Figure 11 - Results of GWAS p-values and cross-validated predictive ability for Mn55
Comparison of p-values and predictive ability
Genome-wide association mapping via Wilcoxon test
Predictive ability assessed by cross validation
Supplementary Figure 12 - Results of GWAS p-values and cross-validated predictive ability for Fe56
Comparison of p-values and predictive ability
Genome-wide association mapping via Wilcoxon test
Predictive ability assessed by cross validation
Supplementary Figure 13 - Results of GWAS p-values and cross-validated predictive ability for Co59
Comparison of p-values and predictive ability
Genome-wide association mapping via Wilcoxon test
Predictive ability assessed by cross validation
Supplementary Figure 14 - Results of GWAS p-values and cross-validated predictive ability for Zn66
Comparison of p-values and predictive ability
Genome-wide association mapping via Wilcoxon test
Predictive ability assessed by cross validation
Supplementary Figure 15 - Results of GWAS p-values and cross-validated predictive ability for avrRpm1
Comparison of p-values and predictive ability
Genome-wide association mapping via Wilcoxon test
Predictive ability assessed by cross validation
Supplementary Figure 16 - Results of GWAS p-values and cross-validated predictive ability for FLC
Comparison of p-values and predictive ability
Genome-wide association mapping via Wilcoxon test
Predictive ability assessed by cross validation
Supplementary Figure 17 - Results of GWAS p-values and cross-validated predictive ability for FRI
Comparison of p-values and predictive ability
Genome-wide association mapping via Wilcoxon test
Predictive ability assessed by cross validation
Supplementary Figure 18 - Results of GWAS p-values and cross-validated predictive ability for 8W GH LN
Comparison of p-values and predictive ability
Genome-wide association mapping via Wilcoxon test
Predictive ability assessed by cross validation
Supplementary Figure 19 - Results of GWAS p-values and cross-validated predictive ability for 0W GH LN
Comparison of p-values and predictive ability
Genome-wide association mapping via Wilcoxon test
Predictive ability assessed by cross validation
Supplementary Figure 20 - Results of GWAS p-values and cross-validated predictive ability for FT Diameter Field
Comparison of p-values and predictive ability
Genome-wide association mapping via Wilcoxon test
Predictive ability assessed by cross validation
Supplementary Figure 21 - Results of GWAS p-values and cross-validated predictive ability for At1
Comparison of p-values and predictive ability
Genome-wide association mapping via Wilcoxon test
Predictive ability assessed by cross validation
Supplementary Figure 22 - Results of GWAS p-values and cross-validated predictive ability for At1 CFU2
Comparison of p-values and predictive ability
Genome-wide association mapping via Wilcoxon test
Predictive ability assessed by cross validation
Supplementary Figure 23 - Results of GWAS p-values and cross-validated predictive ability for As CFU2
Comparison of p-values and predictive ability
Genome-wide association mapping via Wilcoxon test
Predictive ability assessed by cross validation
Supplementary Figure 24 - Results of GWAS p-values and cross-validated predictive ability for Bs
Comparison of p-values and predictive ability
Genome-wide association mapping via Wilcoxon test
Predictive ability assessed by cross validation
Supplementary Figure 25 - Results of GWAS p-values and cross-validated predictive ability for Bs CFU2
Comparison of p-values and predictive ability
Genome-wide association mapping via Wilcoxon test
Predictive ability assessed by cross validation
Supplementary Figure 26 - Results of GWAS p-values and cross-validated predictive ability for At2
Comparison of p-values and predictive ability
Genome-wide association mapping via Wilcoxon test
Predictive ability assessed by cross validation
Supplementary Figure 27 - Results of GWAS p-values and cross-validated predictive ability for At2 CFU2
Comparison of p-values and predictive ability
Genome-wide association mapping via Wilcoxon test
Predictive ability assessed by cross validation
Supplementary Figure 28 - Results of GWAS p-values and cross-validated predictive ability for As2
Comparison of p-values and predictive ability
Genome-wide association mapping via Wilcoxon test
Predictive ability assessed by cross validation
Supplementary Figure 29 - Results of GWAS p-values and cross-validated predictive ability for DW
Comparison of p-values and predictive ability
Genome-wide association mapping via Wilcoxon test
Predictive ability assessed by cross validation
Supplementary Figure 30 - Results of GWAS p-values and cross-validated predictive ability for Silique 22
Comparison of p-values and predictive ability
Genome-wide association mapping via Wilcoxon test
Predictive ability assessed by cross validation
Supplementary Figure 31 - Results of GWAS p-values and cross-validated predictive ability for Germ 10
Comparison of p-values and predictive ability
Genome-wide association mapping via Wilcoxon test
Predictive ability assessed by cross validation
Supplementary Figure 32 - Results of GWAS p-values and cross-validated predictive ability for Germ 16
Comparison of p-values and predictive ability
Genome-wide association mapping via Wilcoxon test
Predictive ability assessed by cross validation
Supplementary Figure 33 - Results of GWAS p-values and cross-validated predictive ability for Width 10
Comparison of p-values and predictive ability
Genome-wide association mapping via Wilcoxon test
Predictive ability assessed by cross validation
Supplementary Figure 34 - Results of GWAS p-values and cross-validated predictive ability for Width 16
Comparison of p-values and predictive ability
Genome-wide association mapping via Wilcoxon test
Predictive ability assessed by cross validation
Supplementary Figure 35 - Results of GWAS p-values and cross-validated predictive ability for Width 22
Comparison of p-values and predictive ability
Genome-wide association mapping via Wilcoxon test
Predictive ability assessed by cross validation
Supplementary Figure 36 - Results of GWAS p-values and cross-validated predictive ability for Chlorosis 16
Comparison of p-values and predictive ability
Genome-wide association mapping via Wilcoxon test
Predictive ability assessed by cross validation
Supplementary Figure 37 - Results of GWAS p-values and cross-validated predictive ability for Anthocyanin 10
Comparison of p-values and predictive ability
Genome-wide association mapping via Wilcoxon test
Predictive ability assessed by cross validation
Supplementary Figure 38 - Results of GWAS p-values and cross-validated predictive ability for Anthocyanin 16
Comparison of p-values and predictive ability
Genome-wide association mapping via Wilcoxon test
Predictive ability assessed by cross validation
Supplementary Figure 39 - Results of GWAS p-values and cross-validated predictive ability for Anthocyanin 22
Comparison of p-values and predictive ability
Genome-wide association mapping via Wilcoxon test
Predictive ability assessed by cross validation
Supplementary Figure 40 - Results of GWAS p-values and cross-validated predictive ability for Leaf serr 10
Comparison of p-values and predictive ability
Genome-wide association mapping via Wilcoxon test
Predictive ability assessed by cross validation
Supplementary Figure 41 - Results of GWAS p-values and cross-validated predictive ability for Leaf roll 16
Comparison of p-values and predictive ability
Genome-wide association mapping via Wilcoxon test
Predictive ability assessed by cross validation
Supplementary Figure 42 - Results of GWAS p-values and cross-validated predictive ability for Rosette Erect 22
Comparison of p-values and predictive ability
Genome-wide association mapping via Wilcoxon test
Predictive ability assessed by cross validation
Supplementary Figure 43 - Results of GWAS p-values and cross-validated predictive ability for Seedling Growth
Comparison of p-values and predictive ability
Genome-wide association mapping via Wilcoxon test
Predictive ability assessed by cross validation
Supplementary Figure 44 - Results of GWAS p-values and cross-validated predictive ability for Vern Growth
Comparison of p-values and predictive ability
Genome-wide association mapping via Wilcoxon test
Predictive ability assessed by cross validation
Supplementary Figure 45 - Results of GWAS p-values and cross-validated predictive ability for After Vern Growth
Comparison of p-values and predictive ability
Genome-wide association mapping via Wilcoxon test
Predictive ability assessed by cross validation
Supplementary Figure 46 - Results of GWAS p-values and cross-validated predictive ability for Secondary
Dormancy
Comparison of p-values and predictive ability
Genome-wide association mapping via Wilcoxon test
Predictive ability assessed by cross validation
Supplementary Figure 47 - Results of GWAS p-values and cross-validated predictive ability for Germ in dark
Comparison of p-values and predictive ability
Genome-wide association mapping via Wilcoxon test
Predictive ability assessed by cross validation
Supplementary Figure 48 - Results of GWAS p-values and cross-validated predictive ability for DSDS50
Comparison of p-values and predictive ability
Genome-wide association mapping via Wilcoxon test
Predictive ability assessed by cross validation
Supplementary Figure 49 - Results of GWAS p-values and cross-validated predictive ability for Storage 56 days
